Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Since the march 2012 notification zimmer has monitored the occurrence of non-compatible micro component combinations being implanted. this included the usage of micro femurs and micro patellae in addition to micro articular surfaces. although the occurrence has been reduced since the 2012 notification it has not been eliminated and therefore zimmer is initiating a recall to remove the affected devices [implants and provisionals (a reusable joint specific trial device used in orthopedic joint replacement to validate the proper size of the permanent prosthesis)] and prevent this issue from recurring.
Model Catalog: 00-5879-067-29 (Lot serial: ALL LOTS); Model Catalog: 00-5879-067-26 (Lot serial: ALL LOTS); Model Catalog: 00-5878-061-26 (Lot serial: ALL LOTS); Model Catalog: 00-5878-061-29 (Lot serial: ALL LOTS); Model Catalog: 00-5878-061-32 (Lot serial: ALL LOTS); Model Catalog: 00-5878-061-35 (Lot serial: ALL LOTS); Model Catalog: 00587906126 (Lot serial: ALL LOTS); Model Catalog: 00587906129 (Lot serial: ALL LOTS); Model Catalog: 00587906132 (Lot serial: ALL LOTS); Model Catalog: 00587906135 (Lot serial: ALL LOTS)
“The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.